News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
151 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18664)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1140)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (80)
7 (151)
8 (89)
9 (81)
10 (30)
13 (140)
14 (106)
15 (102)
16 (129)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
Press Releases
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
July 7, 2026
·
8 min read
Press Releases
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
July 7, 2026
·
10 min read
Press Releases
West to Host Second-Quarter 2026 Conference Call
July 7, 2026
·
1 min read
Press Releases
TIXiMED Initiates Phase 1b Multiple Ascending Dose Study of TIX100
July 7, 2026
·
3 min read
Press Releases
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
July 7, 2026
·
8 min read
Press Releases
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
July 7, 2026
·
1 min read
Press Releases
Aclarion Announces Texas Spine Care Center as New CLARITY Site
July 7, 2026
·
6 min read
Press Releases
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
July 7, 2026
·
3 min read
Press Releases
ImageneBio Appoints Matt Robbins as General Counsel
July 7, 2026
·
4 min read
Press Releases
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
July 7, 2026
·
15 min read
Previous
4 of 16
Next